文献速递耳科与耳神经小儿耳鼻咽喉

1998年至2019年先天性巨细胞病毒感染的国家与地区趋势

National and Regional Trends in Congenital Cytomegalovirus Infection From 1998 to 2019.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-01-05

该横断面研究利用美国国家住院患者样本数据库1998至2019年数据,分析新生儿先天性巨细胞病毒(cCMV)诊断率的时间变化及新生儿听力筛查(NBHS)项目实施的可能影响。每100万活产中cCMV诊断总数从1998年109例增至2019年250例,估计年增6.89例(95%CI 5.43-8.35,P<.001);伴听力损失的cCMV诊断年增0.87例(95%CI 0.51-1.22,P<.001)。与NBHS实施前相比,东北部(P<.001)和南部(P=.008)实施后cCMV诊断率增长显著更高。

要点

  • 每100万活产cCMV诊断数从1998年109例增至2019年250例,年增6.89例(95%CI 5.43-8.35,P<.001)。
  • 伴听力损失的cCMV诊断年增0.87例(95%CI 0.51-1.22,P<.001),其中无症状者年增0.18例(P=.02)、有症状者年增0.68例(P<.001)。
  • 与NBHS实施前相比,东北部(P<.001)和南部(P=.008)实施后cCMV诊断率增长显著更高。

核心结论

  • 州级NBHS项目实施与cCMV诊断率上升相关,但cCMV教育和意识提升可能也有贡献。
  • cCMV在一个大型国家数据库中仍存在诊断不足。

研究设计与样本

  • 横断面研究,数据来源为美国国家住院患者样本(NIS)数据库1998至2019年出院数据。
  • 通过国际疾病分类编码识别cCMV感染新生儿,并分为无症状与有症状、伴或不伴听力损失。
  • 采用线性回归和中断时间序列分析评估诊断率随时间的变化,中断分析基于各地区NBHS实施时间。

主要发现

  • 每100万活产中,cCMV诊断总数从1998年109例增至2019年250例,估计年增6.89例(95%CI 5.43-8.35,P<.001)。
  • 伴听力损失的cCMV诊断年增0.87例(95%CI 0.51-1.22,P<.001),其中无症状者年增0.18例(95%CI 0.03-0.32,P=.02),有症状者年增0.68例(95%CI 0.37-0.99,P<.001)。
  • 与NBHS实施前相比,东北部NBHS实施后cCMV诊断率增长显著更高(P<.001),南部亦显著更高(P=.008)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze temporal changes and to assess the possible effect of newborn hearing screening (NBHS) programs on changes in congenital cytomegalovirus (cCMV) diagnostic rates in the United States. STUDY DESIGN: Cross-sectional study. SETTING: National Inpatient Sample (NIS) database. METHODS: Neonates with cCMV infection were identified using discharge data from the NIS database from 1998 to 2019. Neonates with cCMV infection were identified via International Classification of Diseases codes and categorized as asymptomatic versus symptomatic and with or without hearing loss. Linear regression and interrupted time series analyses were conducted to analyze changes in diagnostic rates over time. Interrupted analyses were based on the timing of NBHS implementation in geographic regions. RESULTS: Per 1,000,000 live births, the estimated total number of cCMV diagnoses increased from 109 in 1998 to 250 in 2019 (the estimated annual increase per 1,000,000 live births is 6.89 ([95% confidence interval, 5.43-8.35], P < .001). Diagnosis of cCMV with hearing loss showed a significant annual increase during this time (0.87 [0.51-1.22], P < .001), and within this group, diagnosis of both asymptomatic (0.18 [0.03-0.32], P = .02) and symptomatic (0.68 [0.37-0.99], P < .001) cases increased significantly. Compared to pre-NBHS, the rate of increase in cCMV diagnosis was significantly higher post-NBHS implementation in the Northeast (P < .001) and South (P = .008). CONCLUSION: Implementation of state NBHS programs correlated with increasing diagnosis rates of cCMV, though cCMV education and awareness may be contributing. cCMV continues to be underdiagnosed in a large national database.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. So RJ, Noij KS, Wang J, et al. National and Regional Trends in Congenital Cytomegalovirus Infection From 1998 to 2019. Otolaryngol Head Neck Surg. 2025. PMID: 39756017. doi:10.1002/ohn.1107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。